Arie Belldegrun - 30 Sep 2025 SCHEDULE 13G/A Report for Allogene Therapeutics, Inc. Common Stock (ALLO)

Filing Manager
Arie Belldegrun
Reporting Manager
Arie Belldegrun, M.D.
Symbol
ALLO
Shares outstanding
226,220,429 shares
Disclosed Ownership
12,668,344 shares
Ownership
5.6%
Form type
SCHEDULE 13G/A
Filing time
13 Nov 2025, 19:09:38 UTC
Date of event
30 Sep 2025
Previous filing
12 Aug 2025
Next filing
17 Feb 2026

Quoteable Key Fact

"Arie Belldegrun disclosed 5.6% ownership in Allogene Therapeutics, Inc. Common Stock (ALLO) on 30 Sep 2025."

Quick Takeaways

  • Arie Belldegrun filed SCHEDULE 13G/A for Allogene Therapeutics, Inc. Common Stock (ALLO).
  • Disclosed ownership: 5.6%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 12 Aug 2025.
  • Current filing was accepted on 13 Nov 2025, 19:09.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Arie Belldegrun, M.D. 5.6% 12,668,344 3,896,057 8,772,287 /s/ Arie Belldegrun Arie Belldegrun, M.D.
Bellco Legacy LLC 0.2% 539,867 0 539,867 /s/ Arie Belldegrun By Arie Belldegrun, M.D., Manager
Bellco Legacy IV LLC 2.1% 4,710,120 0 4,710,120 /s/ Arie Belldegrun By Arie Belldegrun, M.D., Manager
Vida Ventures LLC 0.8% 1,798,163 0 1,798,163 /s/ Arie Belldegrun By VV Manager LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,
Vida Ventures III, L.P. 0.8% 1,720,172 0 1,720,172 /s/ Arie Belldegrun By Vida Ventures GP III, LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,
Vida Ventures III-A, L.P. 0% 3,965 0 3,965 /s/ Arie Belldegrun By Vida Ventures GP III, LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,